Morten Harket, the beloved front man of the pop-synth group A-ha, shared some heartbreaking health news with fans recently in a story posted on the band’s website. That news? He is battling ...

Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders Lab showed that small aggregates of alpha-synuclein ...

Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders Lab is deciphering the role of aggregation and ...

The STEPS 2 trial is led by Professor Paul Taylor at Salisbury District Hospital, in partnership with the University of Southampton, University of Plymouth, and the University of Exeter. Funding is ...

Bacteria in the mouth and gut may play a significant role in the progression of cognitive decline in Parkinson’s disease, ...

Description: Changes in gut and oral bacteria are linked to worsening cognitive symptoms in people with Parkinson's disease.

The first cohort in the ongoing clinical Phase 2a study EXIST evaluated a lower dose of exidavnemab compared to placebo in patients with Parkinson’s disease. An interim safety review showed that ...

A new study suggests long-term exposure to chemicals used to keep fairways green may be tied to an increased risk of ...

Parkinson's disease is a progressive and common neurodegenerative condition, typically characterized by involuntary shaking, ...

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

New research links high consumption of ultra-processed foods to early signs of Parkinson’s disease, raising fresh concerns ...

The FDA has approved Capsida Biotherapeutics' investigational new drug (IND) application for CAP-003 to treat Parkinson’s ...